Solid Biosciences's three largest insider shareholders as of March 23, 2026 are Capital Life Sciences Investors, Llc Bain (TenPercentOwner, 5.03Mn shares), Adam Koppel (Director, 4.03Mn shares), Joel Solomon Zev Schneider (Chief Operating Officer, 236.27K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Capital Life Sciences Investors, Llc Bain | 0 | 5,034,582 | 21 Feb, 2025 | |
| Adam Koppel | 0 | 4,034,582 | 12 Jan, 2024 | |
| Joel Solomon Zev Schneider | Chief Operating Officer | 236,270 | 0 | 15 Mar, 2022 |
| Alexander Cumbo | President And Ceo | 235,405 | 0 | 18 Feb, 2026 |
| Kevin Tan | Cfo Treasurer | 99,422 | 0 | 18 Feb, 2026 |
| Ilan Ganot | 99,297 | 0 | 29 Jan, 2026 | |
| Gabriel Brooks | Chief Medical Officer | 95,029 | 0 | 18 Feb, 2026 |
| Jessie Hanrahan | Chief Regulatory Officer | 74,318 | 0 | 18 Feb, 2026 |
| Paul Herzich | Chief Technology Officer | 72,638 | 0 | 18 Feb, 2026 |
| Ilan Ganot | 0 | 27,474 | 18 Feb, 2026 | |
| Carl Ashley Morris | Chief Scientific Officer | 19,760 | 0 | 31 Jan, 2023 |
| Jennifer Marlowe | Cso | 6,998 | 0 | 05 Dec, 2023 |
| Clare Kahn | 2,960 | 0 | 13 Mar, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 13 Feb, 2026 | Alexander Cumbo | Common Stock | A | 30,031 | - | 252,049 | D | M |
| 13 Feb, 2026 | Jessie Hanrahan | Common Stock | A | 8,125 | - | 78,452 | D | M |
| 13 Feb, 2026 | Kevin Tan | Common Stock | A | 10,625 | - | 104,826 | D | M |
| 13 Feb, 2026 | Ilan Ganot | Common Stock | A | 4,861 | - | 30,132 | I | M |
| 13 Feb, 2026 | Gabriel Brooks | Common Stock | A | 10,937 | - | 95,029 | D | M |
| 13 Feb, 2026 | Paul Herzich | Common Stock | A | 7,187 | - | 76,254 | D | M |
| 18 Feb, 2026 | Alexander Cumbo | Common Stock | D | 16,644 | $5.82 | 235,405 | D | S |
| 18 Feb, 2026 | Paul Herzich | Common Stock | D | 3,616 | $5.82 | 72,638 | D | S |
| 18 Feb, 2026 | Ilan Ganot | Common Stock | D | 2,658 | $5.82 | 27,474 | I | S |
| 18 Feb, 2026 | Kevin Tan | Common Stock | D | 5,404 | $5.82 | 99,422 | D | S |
| 18 Feb, 2026 | Jessie Hanrahan | Common Stock | D | 4,134 | $5.82 | 74,318 | D | S |
| 13 Feb, 2026 | Alexander Cumbo | Restricted Stock Units | D | 30,031 | $0.00 | 60,063 | D | M |
| 13 Feb, 2026 | Paul Herzich | Restricted Stock Units | D | 7,187 | $0.00 | 14,376 | D | M |
| 13 Feb, 2026 | Kevin Tan | Restricted Stock Units | D | 10,625 | $0.00 | 21,250 | D | M |
| 13 Feb, 2026 | Jessie Hanrahan | Restricted Stock Units | D | 8,125 | $0.00 | 16,250 | D | M |
| 13 Feb, 2026 | Gabriel Brooks | Restricted Stock Units | D | 10,937 | $0.00 | 21,876 | D | M |
| 13 Feb, 2026 | Ilan Ganot | Restricted Stock Units | D | 4,861 | $0.00 | 9,722 | I | M |
| 04 Feb, 2026 | Paul Herzich | Common Stock | D | 10,905 | $6.44 | 69,067 | D | S |
| 04 Feb, 2026 | Alexander Cumbo | Common Stock | D | 48,913 | $6.44 | 222,018 | D | S |
| 04 Feb, 2026 | Gabriel Brooks | Common Stock | D | 12,616 | $6.44 | 84,092 | D | S |